Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
OptimizeRx Corp. (OPRX) had Normalized Pre-Tax Income of $6.95M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$109.43M |
|
$5.13M |
|
$35.83M |
|
$73.59M |
|
$97.74M |
|
$11.69M |
|
$-4.74M |
|
$6.95M |
|
|
Normalized Pre-Tax Income |
$6.95M |
$5.13M |
|
$5.13M |
|
$5.13M |
|
$5.13M |
|
$11.69M |
|
$17.13M |
|
18.55M |
|
19.00M |
|
$0.28 |
|
$0.27 |
|
| Balance Sheet Financials | |
$64.72M |
|
$0.11M |
|
$112.20M |
|
$176.92M |
|
$21.26M |
|
$21.42M |
|
$27.36M |
|
$48.62M |
|
$128.29M |
|
$16.63M |
|
$128.29M |
|
18.76M |
|
| Cash Flow Statement Financials | |
$18.71M |
|
$0.07M |
|
$-8.80M |
|
$13.38M |
|
$23.36M |
|
$9.98M |
|
$6.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|